<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39252866</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.</ArticleTitle><Pagination><StartPage>102787</StartPage><MedlinePgn>102787</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102787</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102787</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">It is unknown if early COVID-19 monoclonal antibody (mAb) therapy can reduce risk of Long COVID. The mAbs amubarvimab/romlusevimab were previously demonstrated to reduce risk of hospitalization/death by 79%. This study assessed the impact of amubarvimab/romlusevimab on late outcomes, including Long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Non-hospitalized high-risk adults within 10 days of COVID-19 symptom onset enrolled in a randomized, double-blind, placebo-controlled phase 2/3 trial of amubarvimab/romlusevimab for COVID-19 treatment. Late symptoms, assessed using a participant-completed symptom diary, were a pre-specified exploratory endpoint. The primary outcome for this analysis was the composite of Long COVID by participant self-report (presence of COVID-19 symptoms as recorded in the diary at week 36) or hospitalization or death by week 36. Inverse probability weighting (IPW) was used to address incomplete outcome ascertainment, giving weighted risk ratios (wRR) comparing amubarvimab/romlusevimab to placebo.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Participants received amubarvimab/romlusevimab (n&#xa0;=&#xa0;390) or placebo (n&#xa0;=&#xa0;390) between January and July 2021. Median age was 49 years, 52% were female, 18% Black/African American, 49% Hispanic/Latino, and 9% COVID-19-vaccinated at entry. At week 36, 103 (13%) had incomplete outcome ascertainment, and 66 (17%) on amubarvimab/romlusevimab and 92 (24%) on placebo met the primary outcome (wRR&#xa0;=&#xa0;0.70, 95% confidence interval (CI) 0.53-0.93). The difference was driven by fewer hospitalizations/deaths with amubarvimab/romlusevimab (4%) than placebo (13%). Among 652 participants with available diary responses, 53 (16%) on amubarvimab/romlusevimab and 44 (14%) on placebo reported presence of Long COVID.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Amubarvimab/romlusevimab treatment, while highly effective in preventing hospitalizations/deaths, did not reduce risk of Long COVID. Additional interventions are needed to prevent Long COVID.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Amubarvimab and romlusevimab supplied by Brii Biosciences.</AbstractText><CopyrightInformation>&#xa9; 2024 Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evering</LastName><ForeName>Teresa H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moser</LastName><ForeName>Carlee</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jilg</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritz</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wohl</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jonathan Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Brigham &amp; Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margolis</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Brii Biosciences, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javan</LastName><ForeName>Arzhang Cyrus</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eron</LastName><ForeName>Joseph J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Currier</LastName><ForeName>Judith S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daar</LastName><ForeName>Eric S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Davey M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>University of California, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Kara W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ACTIV-2/A5401 Study Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UM1 AI069423</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069424</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069419</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI068636</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069412</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI068634</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Monoclonal antibodies</Keyword><Keyword MajorTopicYN="N">Outpatient treatment</Keyword><Keyword MajorTopicYN="N">Post COVID conditions</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection (PASC)</Keyword></KeywordList><CoiStatement>Dr. Evering reports other from AIDS Clinical Trials Group (ACTG), during the conduct of the study; personal fees from Tonix Pharmaceuticals, outside the submitted work. Dr. Moser reports grants from NIH/NIAID, grants from NIH/NIAID, during the conduct of the study. Dr. Jilg reports other from AIDS Clinical Trials Group (ACTG), during the conduct of the study; grants from National Institutes of Health (NIH), grants from Harvard University Center for AIDS Research (HU-CFAR), other from Sagent Pharmaceuticals, outside the submitted work. Mr. Ritz reports grants from NIH/NIAID, grants from NIH/NIAID, during the conduct of the study. Dr. Wohl reports grants and personal fees from Gilead Sciences, grants and personal fees from ViiV Healthcare, grants and personal fees from Merck &amp; Co, personal fees from Janssen Pharmaceuticals, personal fees from BMS, personal fees&#xa0;from Theratechnologies, personal fees from EMD Serono, personal fees from Regeneron, outside the submitted work. Dr. Margolis reports other from BRII Biosciences, outside the submitted work. Dr. Eron reports grants from National Institutes of Health, during the conduct of the study; personal fees from Merck &amp; Co, grants and personal fees from Gilead Sciences, other from Invivyd, outside the submitted work. Dr. Currier reports personal fees from Merck, outside the submitted work. Dr. Daar reports grants from NIH, during the conduct of the study; grants and personal fees from Gilead, grants and personal fees from ViiV, personal fees from Theratechnologies, outside the submitted work. Dr. Smith reports grants from NIH, during the conduct of the study; personal fees from Model Medicines, personal fees from Bayer, personal fees from Gilead, personal fees from Lucira, personal fees from VXBiosciences, personal fees from Linear Therapies, personal fees from Red Queen Therapeutics, other from A2 Bio, personal fees from&#xa0;Pharma Holdings, personal fees from Evidera, personal fees from Hyundai, outside the submitted work. Dr. Hughes reports grants from United States National Institutes of Health, during the conduct of the study. Dr. Chew reports grants from NIH/NIAID, grants from NIH/NCATS, during the conduct of the study; personal fees from Pardes Biosciences, outside the submitted work. The remaining authors have no competing interests to disclose.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Chew</LastName><ForeName>Kara</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>David Davey</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daar</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wohl</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Currier</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eron</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Javan</LastName><ForeName>Arzhang Cyrus</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moser</LastName><ForeName>Carlee</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giganti</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritz</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hosey</LastName><ForeName>Lara</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roa</LastName><ForeName>Jhoanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Nilam</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colsh</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rwakazina</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beck</LastName><ForeName>Justine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sieg</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fischer</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evering</LastName><ForeName>Teresa H</ForeName><Initials>TH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ignacio</LastName><ForeName>Rachel Bender</ForeName><Initials>RB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corado</LastName><ForeName>Katya</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jagannathan</LastName><ForeName>Prasanna</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jilg</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perelson</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pillay</LastName><ForeName>Sandy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riviere</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Upinder</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taiwo</LastName><ForeName>Babafemi</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottesman</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newell</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dragavon</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jennings</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greenfelder</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murtaugh</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kosmyna</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gapara</LastName><ForeName>Morgan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shahkolahi</LastName><ForeName>Akbar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Margolis</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacal</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salusso</LastName><ForeName>Diego</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nu&#xf1;ez</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Marcelo Rodrigo</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laborde</LastName><ForeName>Luciana</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papasidero</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wehbe</LastName><ForeName>Luis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Mariana</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voena</LastName><ForeName>Felicitas Fernandez</ForeName><Initials>FF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopez</LastName><ForeName>Amaru</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huhn</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Andrea Nores</LastName><ForeName>Ulises</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieser</LastName><ForeName>Pablo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bordese</LastName><ForeName>Fernando</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mussi</LastName><ForeName>Marisa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Carvalho Santana</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiraboschi B&#xe1;rbaro</LastName><ForeName>Adriana Aparecida</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Breno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>de C&#xe1;ssia Alves Lira</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machado da Silva</LastName><ForeName>Andre Luiz</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Sandra Wagner</ForeName><Initials>SW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diniz Ribeiro</LastName><ForeName>Maria Pia</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soliva</LastName><ForeName>Nath&#xe1;lia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vasconcellos</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Jorge Eurico</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>En&#xe9;as</LastName><ForeName>Miriam Amaral</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fonseca de Morais Caporali</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faleiro Ferreira</LastName><ForeName>Fl&#xe1;via Gomes</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivera Martinez</LastName><ForeName>Norma Erendira</ForeName><Initials>NE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bohorquez Lopez</LastName><ForeName>Victor Casildo</ForeName><Initials>VC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frias</LastName><ForeName>Melchor Victor</ForeName><Initials>MV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fetalvero</LastName><ForeName>Krystle</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maranan</LastName><ForeName>Alyxzza</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosa</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coetzer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohata</LastName><ForeName>Maureen</ForeName><Initials>M</Initials><Suffix>Sr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Lalloo</LastName><ForeName>Umesh</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pillay</LastName><ForeName>Sandy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madlala</LastName><ForeName>Penelope</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pillay-Ramaya</LastName><ForeName>Larisha</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennet</LastName><ForeName>Jaclyn Ann</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mwelase</LastName><ForeName>Noluthando</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mbhele</LastName><ForeName>Nokuphiwa</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrick</LastName><ForeName>Frederick</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joubert</LastName><ForeName>Leonard</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mbali</LastName><ForeName>Rose</ForeName><Initials>R</Initials><Suffix>Sr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Joseph</LastName><ForeName>Natasha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manentsa</LastName><ForeName>Mmatsie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Walt</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawrance Masilela</LastName><ForeName>Mduduzi Sandile</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zwane</LastName><ForeName>Zinhle</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiperera</LastName><ForeName>Tendai</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohapi</LastName><ForeName>Lerato</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moonsamy</LastName><ForeName>Suri</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Usha</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>McHarry</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snyman</LastName><ForeName>Elizma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lennox</LastName><ForeName>Pieter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Innes</LastName><ForeName>James Craig</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Letlape</LastName><ForeName>Oteng</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jonkane</LastName><ForeName>Olebogeng</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brumskine</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adonis</LastName><ForeName>Tania</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sein</LastName><ForeName>Ni Ni</ForeName><Initials>NN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sebe</LastName><ForeName>Modulakgotla</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vahed</LastName><ForeName>Yacoob</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hussen</LastName><ForeName>Nazreen Jeewa</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitha</LastName><ForeName>Ismail</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheekati</LastName><ForeName>Vasundhara</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheekati</LastName><ForeName>Purna</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lummus</LastName><ForeName>Christie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Idarraga</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pham</LastName><ForeName>David N</ForeName><Initials>DN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kao</LastName><ForeName>Wei-Hsin</ForeName><Initials>WH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>Michael M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Miriam Batule</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malik</LastName><ForeName>Anju</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bryan</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnold</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Idania</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karpf</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Aniuska</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Folkens</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manne</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yawetz</LastName><ForeName>Sigal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keenan</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eziri</LastName><ForeName>Emeka</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fichtenbaum</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baer</LastName><ForeName>Jenifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trentman</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Call</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaughan</LastName><ForeName>Leroy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milstone</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slandzicki</LastName><ForeName>Jamie Alex</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallan</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guillory</LastName><ForeName>Clinton</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andrews</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evering</LastName><ForeName>Teresa H</ForeName><Initials>TH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berardi</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arar</LastName><ForeName>Celine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinn</LastName><ForeName>Randall</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amaya</LastName><ForeName>Jorge P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gomez-Martinez</LastName><ForeName>Marissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cantu</LastName><ForeName>Luis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Betancourt-Garcia</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okeke</LastName><ForeName>Nwora Lance</ForeName><Initials>NL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burns</LastName><ForeName>Charles M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haddad</LastName><ForeName>Fadi</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haddad</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Focil</LastName><ForeName>Augusto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosas</LastName><ForeName>Griselda</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moyano</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rojas</LastName><ForeName>Yaneicy Gonzalez</ForeName><Initials>YG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aswad</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bukhman</LastName><ForeName>Yevgeniy</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jain</LastName><ForeName>Manish</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bukhman</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farah</LastName><ForeName>Humam</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>McClain</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daar</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaik</LastName><ForeName>Sadia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hatlen</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gotur</LastName><ForeName>Deepa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surber</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kingsley</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pixler</LastName><ForeName>April</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zopo</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herman</LastName><ForeName>Jack</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herman</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leon</LastName><ForeName>Ramon</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nikolov</LastName><ForeName>Boris</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vergara</LastName><ForeName>Fernando Gonzalez</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Ana I</ForeName><Initials>AI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Noemi</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gelman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andriunas</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jagizarov</LastName><ForeName>Zarema</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Westerman</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sherer</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dooley</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becker</LastName><ForeName>Becky</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Adaliah</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roman</LastName><ForeName>Eloy</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fern&#xe1;ndez</LastName><ForeName>Heriberto</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mocherla</LastName><ForeName>Bharat</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beck</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maldonado</LastName><ForeName>Valarie</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veltman</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandhi</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shea</LastName><ForeName>Katrina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Planchon</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herpel</LastName><ForeName>Laura Bogan</ForeName><Initials>LB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Kaushlendra K</ForeName><Initials>KK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Day</LastName><ForeName>Donald C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pullman</LastName><ForeName>John</ForeName><Initials>J</Initials><Suffix>Sr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Williams-Leber</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Misty</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hecker</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avery</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoover</LastName><ForeName>Keila</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monlux</LastName><ForeName>George W</ForeName><Initials>GW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Juneja</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Wernick</LastName><ForeName>Arthur</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Karelia</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hern&#xe1;ndez</LastName><ForeName>Maureen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Yadilys</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taiwo</LastName><ForeName>Babafemi O</ForeName><Initials>BO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berzins</LastName><ForeName>Baiba</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malvestutto</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harber</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cicarella</LastName><ForeName>Robyn</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeJesus</LastName><ForeName>Edwin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rolle</LastName><ForeName>Charlotte-Paige</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Free</LastName><ForeName>Almena L</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pulliam</LastName><ForeName>Sallie D</ForeName><Initials>SD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weinstein</LastName><ForeName>Debra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suarez</LastName><ForeName>Rosa M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Socorro</LastName><ForeName>Ezequiel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Socorro</LastName><ForeName>Estefania</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neytman</LastName><ForeName>Gene</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herman</LastName><ForeName>Jack</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herman</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Easley</LastName><ForeName>Raymond</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aziz</LastName><ForeName>Mariam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swiatek</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagpal</LastName><ForeName>Avish</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kompelien</LastName><ForeName>Breanna</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEvoy</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoover</LastName><ForeName>Susan E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lutz</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Just</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Victoria</LastName><ForeName>Yanly B</ForeName><Initials>YB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Upinder</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jagannathan</LastName><ForeName>Prasanna</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pathak</LastName><ForeName>Divya</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ordway</LastName><ForeName>Joshua J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heffner</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weston</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weston</LastName><ForeName>Khalilah</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choudhary</LastName><ForeName>Madhu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sullivano</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osiyemi</LastName><ForeName>Olayemi</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Myriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torna</LastName><ForeName>Odelsey</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clemency</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Varughese</LastName><ForeName>Renoj</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lynch</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chew</LastName><ForeName>Kara</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khodabakhshian</LastName><ForeName>Aleen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fortier</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coyne</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cronin</LastName><ForeName>Alexandrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benson</LastName><ForeName>Constance</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendrickx</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Rosemarie</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luetkemeyer</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendler</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dentoni-Lasofsky</LastName><ForeName>Dennis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rathore</LastName><ForeName>Mobeen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahmoudi</LastName><ForeName>Saniyyah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riaz</LastName><ForeName>Amna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spikes</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>Chase</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wohl</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oakes</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loftis</LastName><ForeName>Amy James</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tebas</LastName><ForeName>Pablo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dube</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Saahir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mendez</LastName><ForeName>Luis M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ignacio</LastName><ForeName>Rachel Bender</ForeName><Initials>RB</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGuffin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jonsson</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jain</LastName><ForeName>Mamta K</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senthil</LastName><ForeName>Smruthi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner-Gray</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>David Davey</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewinski</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azizad</LastName><ForeName>Masoud</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chow</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakatani</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williamson</LastName><ForeName>Derrick</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atriss</LastName><ForeName>Hisham</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caloura</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malla</LastName><ForeName>Midhun</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hazard-Jenkins</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilkin</LastName><ForeName>Aimee</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fayssoux</LastName><ForeName>Jamraus</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seagle</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Presti</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haile</LastName><ForeName>Alem</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39252866</ArticleId><ArticleId IdType="pmc">PMC11381616</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102787</ArticleId><ArticleId IdType="pii">S2589-5370(24)00366-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention  Post-COVID conditions: information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</Citation></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., et al. Characterizing long COVID: deep phenotype of a complex condition. eBioMedicine. 2021;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope A.A., Evering T.H. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Infect Dis Clin North Am. 2022;36(2):379&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843334</ArticleId><ArticleId IdType="pubmed">35636906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine. 2022;40(32):4424&#x2013;4431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J.A., McComsey G.A. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large national health research network. Open Forum Infect Dis. 2022;9(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med. 2023;183(6):554&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L., Meli G., Poletti F., et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM. 2022;114(12):865&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ. 2023;381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10126525</ArticleId><ArticleId IdType="pubmed">37161995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. 2023;23(10):1119&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebo K.A., Heath S.L., Fukuta Y., et al. Early antibody treatment, inflammation, and risk of post-COVID conditions. mBio. 2023;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10653913</ArticleId><ArticleId IdType="pubmed">37724870</ArticleId></ArticleIdList></Reference><Reference><Citation>Brii Biosciences . 2021. BRII-198 investigator's brochure - edition: 3.0.</Citation></Reference><Reference><Citation>Brii Biosciences . BRII-196 investigator&#x2019;s brochure - edition: 3.0. 2021.</Citation></Reference><Reference><Citation>Currier J.S., Moser C., Eron J.J., et al. ACTIV-2: a platform trial for the evaluation of novel therapeutics for the treatment of early COVID-19 in outpatients. J&#xa0;Infect Dis. 2023;228(Suppl 2):S77&#x2013;S82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10469341</ArticleId><ArticleId IdType="pubmed">37650231</ArticleId></ArticleIdList></Reference><Reference><Citation>Evering T.H., Chew K.W., Giganti M.J., et al. Safety and efficacy of combination SARS-CoV-2 neutralizing monoclonal antibodies amubarvimab plus romlusevimab in nonhospitalized patients with COVID-19. Ann Intern Med. 2023;176(5):658&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10150320</ArticleId><ArticleId IdType="pubmed">37068272</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser C.B., Chew K.W., Ritz J., et al. Pooling different placebos as a control group in a randomized platform trial: benefits and challenges from experience in the ACTIV-2 COVID-19 trial. J&#xa0;Infect Dis. 2023;228(Suppl 2):S92&#x2013;S100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10686688</ArticleId><ArticleId IdType="pubmed">37650234</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew K.W., Moser C., Daar E.S., et al. Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2022;13(1):4931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9395368</ArticleId><ArticleId IdType="pubmed">35995785</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Gudex C., Lloyd A., et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20(10):1727&#x2013;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J.E., Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Evering T.H., Moser C.B., Jilg N., et al. Long COVID after bamlanivimab treatment. J&#xa0;Infect Dis. 2023;228(Suppl 2):S126&#x2013;S135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10686694</ArticleId><ArticleId IdType="pubmed">37650236</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G. A&#xa0;modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n M.A., Robins J.M. Chapman &amp; Hall/CRC; Boca Raton: 2020. Causal inference: what if.</Citation></Reference><Reference><Citation>Mansournia M.A., Nazemipour M. Recommendations for accurate reporting in medical research statistics. Lancet. 2024;403(10427):611&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">38368003</ArticleId></ArticleIdList></Reference><Reference><Citation>Margalit I., Yelin D., Sagi M., et al. Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study. Clin Infect Dis. 2022;75(10):1688&#x2013;1697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383780</ArticleId><ArticleId IdType="pubmed">35403679</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A., Wynberg E., van Willigen H.D.G., et al. Severe fatigue in the first year following SARS-CoV-2 infection: a prospective cohort study. Open Forum Infect Dis. 2022;9(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8995073</ArticleId><ArticleId IdType="pubmed">35415196</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside D.M., Basso M.R., Naini S.M., et al. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 1: cognitive functioning. Clin Neuropsychol. 2022;36:806&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen L.T., Mukerji S.S., Mejia N.I. Post-acute neurological consequences of COVID-19: an unequal burden. Nat Med. 2022;28(1):20&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Post-COVID conditions: information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</Citation></Reference><Reference><Citation>Brodin P., Casari G., Townsend L., et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28(5):879&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao X., Zhang Z., Ma J., et al. Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults. Front Pharmacol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9486188</ArticleId><ArticleId IdType="pubmed">36147329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Certara  COVID-19: viral kinetic model 2020. https://www.covidpharmacology.com/in-silico-workbench/viral-kinetic-model/ Available from:</Citation></Reference><Reference><Citation>Hwang I.K., Shih W.J., De Cani J.S. Group sequential designs using a family of type I error probability spending functions. Stat Med. 1990;9(12):1439&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pubmed">2281231</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryce C., Grimes Z., Pujadas E., et al. Pathophysiology of SARS-CoV-2: the mount sinai COVID-19 autopsy experience. Mod Pathol. 2021;34(8):1456&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015313</ArticleId><ArticleId IdType="pubmed">33795830</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T., Borzikowsky C., Lieb W., et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. eClinicalMedicine. 2022;51</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam N., Madathil S., Tahani N., et al. Medium-term outcomes in severely to critically ill patients with severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2022;74(2):301&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135551</ArticleId><ArticleId IdType="pubmed">33893486</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A., Wynberg E., van Willigen H.D.G., et al. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study. BMC Med. 2022;20(1):422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9629769</ArticleId><ArticleId IdType="pubmed">36324167</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>